Skip to Content

Tag: CPAP Therapy


Also Noted

Researchers use grant to ID risk for cardiovascular disease in OSA patients 

March 12, 2024HME News Staff

NEW YORK – Mount Sinai researchers have received a $3 million grant from the National Institutes of Health to develop and study AI-powered models to identify the risk of cardiovascular disease events in patients with obstructive sleep apnea. Researchers will use machine-learning techniques on comprehensive multi-modal datasets to identify patients at enhanced risk for buildup of fats and cholesterol in the artery walls, and heightened risk for cardiovascular events such as heart attack and...

Artificial Intelligence (AI), Cardiovascular Disease (CVD), CPAP Therapy


Read Full Articlered right arrow icon

Also Noted

EnsoData, React Health partner 

October 30, 2023HME News Staff

MADISON, Wis., and SARASOTA, Fla. – EnsoData has partnered with React Health to optimize CPAP adherence support for patients with sleep apnea. As part of the partnership, EnsoData’s adherence prediction AI technology will be integrated into React Health’s recently launched Connect patient management software platform, empowering physicians and HME providers with actionable data to provide timely, personalized support to patients who are struggling with therapy. “By partnering...

Adherence, CPAP Therapy, EnsoData, React Health


Read Full Articlered right arrow icon

Also Noted

sovaSage integrates with React Health 

October 30, 2023HME News Staff

PITTSBURGH – sovaSage has completed an integration with React Health’s Connect patient management software platform. Earlier this year, sovaSage introduced Jeanie, an AI-based CPAP coach technology, to manage the initial 90-day compliance period and long-term compliance and support. “React Health has made significant inroads in the sleep therapy market and has established itself as a strong provider of sleep products and technology,” said William Kaigler, founder and CEO of...

Adherence, CPAP Therapy, React Health, sovaSage


Read Full Articlered right arrow icon

Vendors

sovaSage's Jeanie grants ‘strategic advantage’ 

June 2, 2023Liz Beaulieu, Editor

PITTSBURGH – sovaSage is in a “huge growth cycle,” with a new product for patients on CPAP therapy called TherapistAssist Jeanie and a number of key hires, says William Kaigler, co-founder.  The company had a soft launch for Jeanie, an artificial intelligence-based virtual coach that delivers customized written and video-based content to patients 24/7/365, at Medtrade in March.  “There’s nothing else like it,” said Kaigler, who previously founded...

CPAP Therapy, sovaSage, TherapistAssist Jeanie


Read Full Articlered right arrow icon

Also Noted

Sleep Solutions patients see benefit of V-Com 

March 31, 2023HME News Staff

DETROIT – Sleep Solutions, an HME provider based here, recently completed a trial of 100 patients starting CPAP therapy, with 50 patients receiving standard care and 50 patients receiving standard care with the V-Com device. The provider found 12% more of those using V-Com group met the 90-day CMS requirement for adherence. “Most importantly, this is wonderful for the health of our patients,” said Robyn Parrot, president of Sleep Solutions. “But these results also improve...

Adherence, CPAP Therapy, sleep solutions, V-Com


Read Full Articlered right arrow icon

Also Noted

Study finds statins, but not CPAP therapy, can reduce heart disease

March 22, 2023HME News Staff

NEW YORK – A new study from Columbia University researchers suggests that cholesterol-lowering drugs called statins can potentially reduce heart disease in people with obstructive sleep apnea. But, while CPAP therapy improves sleep quality and reduces daytime fatigue in people with OSA, findings from several recent clinical trials show it does not improve heart health as physicians originally hoped, according to a press release by Columbia University Irving Medical Center. “Alternative...

CPAP Therapy, Heart disease, statins


Read Full Articlered right arrow icon

Also Noted

Sleeplay expands foothold 

March 6, 2023HME News Staff

MIAMI – Sleeplay, an online sleep provider, has launched a mobile application. The app, available on the App Store and Google Play Store, will give customers access to online CPAP experts, user-friendly upload Rx for fast order placement and visibility into past orders, the company says. “We’re thrilled to announce the launch of the Sleeplay app and expand our foothold in the CPAP and luxury sleep space,” said Aaron Fuhrman, founder and director of Sleeplay. “Adapting...

CPAP Therapy, Mobile app, Online, Provider, Sleeplay


Read Full Articlered right arrow icon

Also Noted

React Health partners with SleepRes 

February 13, 2023HME News Staff

SARASOTA, Fla. – React Health has a new distribution agreement with SleepRes to provide V-Com with new CPAP orders in the United States. V-Com is placed between the CPAP mask and hose to reduce inspiratory pressure and flow, providing comfort with minimal to no reduction in expiratory pressure (EPAP). “React Health is committed to providing innovative options to improve comfort and patient tolerance to PAP therapy,” said Clint Geffert, president, commercial operations, Reach Health....

CPAP Therapy, React Health, SleepRes, V-Com


Read Full Articlered right arrow icon

Also Noted

AASM launches ‘More than a Snore’ 

February 7, 2023HME News Staff

DARIEN, Ill. - The American Academy of Sleep Medicine has launched a new national campaign called “More than a Snore” to raise awareness of obstructive sleep apnea. “This campaign will raise national awareness of obstructive sleep apnea and encourage undiagnosed patients to advocate for themselves and seek treatment,” said Jennifer Martin, a licensed clinical psychologist and president of the AASM. “It is important that patients and health care professionals feel confident...

American Academy of Sleep Medicine (AASM), CPAP Therapy, Sleep Apnea


Read Full Articlered right arrow icon

Vendors

ResMed reports ‘strong sales growth’ 

January 26, 2023HME News Staff

SAN DIEGO – ResMed reported revenue increased by 16% to $1.03 billion in the second quarter of fiscal year 2023 compared to the same period the previous year.  Net income was $224.9 million vs. $216.2 million.  “During the second quarter, we significantly increased production and delivery of flow generator devices to meet the incredible demand from customers, resulting in strong sales growth in the Americas, and solid overall performance for our business across 140 countries,”...

CPAP Therapy, ResMed


Read Full Articlered right arrow icon